These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 2145753

  • 1. Experimental studies of the physiologic properties of technetium-99m agents: myocardial transport of perfusion imaging agents.
    Meerdink DJ, Leppo JA.
    Am J Cardiol; 1990 Oct 16; 66(13):9E-15E. PubMed ID: 2145753
    [Abstract] [Full Text] [Related]

  • 2. Physiological basis of myocardial perfusion imaging with the technetium 99m agents.
    Beller GA, Watson DD.
    Semin Nucl Med; 1991 Jul 16; 21(3):173-81. PubMed ID: 1835136
    [Abstract] [Full Text] [Related]

  • 3. Experimental studies of the physiologic properties of technetium-99m isonitriles.
    Beller GA, Sinusas AJ.
    Am J Cardiol; 1990 Oct 16; 66(13):5E-8E. PubMed ID: 2145747
    [Abstract] [Full Text] [Related]

  • 4. Prediction of myocardial viability: Tl-201 versus sestamibi versus teboroxime compared with FDG uptake.
    Kiser JW, Drane WE, Mastin ST, Nicole MW.
    Clin Nucl Med; 1998 Jul 16; 23(7):432-6. PubMed ID: 9676947
    [Abstract] [Full Text] [Related]

  • 5. Physiologic properties of myocardial perfusion tracers.
    Dahlberg ST, Leppo JA.
    Cardiol Clin; 1994 May 16; 12(2):169-85. PubMed ID: 8033171
    [Abstract] [Full Text] [Related]

  • 6. The new 99mTc myocardial perfusion imaging agents: 99mTc-sestamibi and 99mTc-teboroxime.
    Berman DS, Kiat H, Maddahi J.
    Circulation; 1991 Sep 16; 84(3 Suppl):I7-21. PubMed ID: 1832100
    [Abstract] [Full Text] [Related]

  • 7. Comparison of technetium-99m sestamibi and thallium-201 retention characteristics in canine myocardium.
    Melon PG, Beanlands RS, DeGrado TR, Nguyen N, Petry NA, Schwaiger M.
    J Am Coll Cardiol; 1992 Nov 01; 20(5):1277-83. PubMed ID: 1401632
    [Abstract] [Full Text] [Related]

  • 8. Myocardial kinetics of (201)Thallium, (99m)Tc-tetrofosmin, and (99m)Tc-sestamibi in an acute ischemia-reperfusion model using isolated rat heart.
    Fukushima K, Momose M, Kondo C, Kusakabe K, Kasanuki H.
    Ann Nucl Med; 2007 Jul 01; 21(5):267-73. PubMed ID: 17634844
    [Abstract] [Full Text] [Related]

  • 9. Comparison of SPECT using technetium-99m agents and thallium-201 and PET for the assessment of myocardial perfusion and viability.
    Berman DS, Kiat H, Van Train KF, Friedman J, Garcia EV, Maddahi J.
    Am J Cardiol; 1990 Oct 16; 66(13):72E-79E. PubMed ID: 2145750
    [Abstract] [Full Text] [Related]

  • 10. Myocardial perfusion imaging with technetium-99m-labeled agents.
    Maddahi J, Kiat H, Berman DS.
    Am J Cardiol; 1991 May 21; 67(14):27D-34D. PubMed ID: 1827941
    [Abstract] [Full Text] [Related]

  • 11. Technetium-99m hexakis 2-methoxy-2-isobutyl isonitrile and thallium-201 extraction, washout, and retention at varying coronary flow rates in rabbit heart.
    Marshall RC, Leidholdt EM, Zhang DY, Barnett CA.
    Circulation; 1990 Sep 21; 82(3):998-1007. PubMed ID: 2394016
    [Abstract] [Full Text] [Related]

  • 12. Advances in myocardial perfusion imaging: 99mTc-teboroxime.
    Pieri PL, Strauss HW.
    J Nucl Biol Med (1991); 1992 Sep 21; 36(2 Suppl):22-8. PubMed ID: 1450239
    [No Abstract] [Full Text] [Related]

  • 13. Clinical experience with technetium-99m teboroxime, a neutral, lipophilic myocardial perfusion imaging agent.
    Johnson LL, Seldin DW.
    Am J Cardiol; 1990 Oct 16; 66(13):63E-67E. PubMed ID: 2220625
    [Abstract] [Full Text] [Related]

  • 14. [Myocardial scintigraphy with Tc-99m-teboroxime: its feasibility and the evaluation of its diagnostic reliability. A comparison with thallium-201 and coronary angiography].
    Bisi G, Sciagrà R, Santoro GM, Cerisano G, Vella A, Zerauschek F, Fazzini PF.
    G Ital Cardiol; 1992 Jul 16; 22(7):795-805. PubMed ID: 1473653
    [Abstract] [Full Text] [Related]

  • 15. Myocardial perfusion imaging with technetium-99m sestamibi SPECT in the evaluation of coronary artery disease.
    Maddahi J, Kiat H, Van Train KF, Prigent F, Friedman J, Garcia EV, Alazraki N, DePuey EG, Nichols K, Berman DS.
    Am J Cardiol; 1990 Oct 16; 66(13):55E-62E. PubMed ID: 2145748
    [Abstract] [Full Text] [Related]

  • 16. Myocardial uptake of (99m)Tc-N-NOET and (201)Tl during dobutamine infusion. Comparison with adenosine stress.
    Calnon DA, Ruiz M, Vanzetto G, Watson DD, Beller GA, Glover DK.
    Circulation; 1999 Oct 12; 100(15):1653-9. PubMed ID: 10517738
    [Abstract] [Full Text] [Related]

  • 17. Teboroxime, sestamibi and thallium-201 as markers of myocardial hypoperfusion: comparison by quantitative dual-isotope autoradiography in rabbits.
    Weinstein H, Reinhardt CP, Leppo JA.
    J Nucl Med; 1993 Sep 12; 34(9):1510-7. PubMed ID: 8355072
    [Abstract] [Full Text] [Related]

  • 18. Technetium-labeled myocardial perfusion agents.
    Heo J, Iskandrian AS.
    Cardiol Clin; 1994 May 12; 12(2):187-98. PubMed ID: 8033172
    [Abstract] [Full Text] [Related]

  • 19. Effects of adenosine and a selective A2A adenosine receptor agonist on hemodynamic and thallium-201 and technetium-99m-sestaMIBI biodistribution and kinetics.
    Mekkaoui C, Jadbabaie F, Dione DP, Meoli DF, Purushothaman K, Belardinelli L, Sinusas AJ.
    JACC Cardiovasc Imaging; 2009 Oct 12; 2(10):1198-208. PubMed ID: 19833310
    [Abstract] [Full Text] [Related]

  • 20. New agents labelled with technetium 99m for myocardial perfusion imaging.
    Taillefer R.
    Can Assoc Radiol J; 1992 Aug 12; 43(4):258-66. PubMed ID: 1386280
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.